elongin A3 family member D, pseudogeneGenealiases: ELOA3D · ELOA3L2 · TCEB3CL2
Q-omics provides the consensus-scored ELOA3DP profile across patient tissues and cancer cell-line models. ELOA3DP expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, ELOA3DP RNA expression shows 3,426 significant gene co-expression associations, with the highest sampling consensus in BRCA. Together, these results highlight BLCA, and BRCA as cancer lineages where ELOA3DP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ELOA3DP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ELOA3DP survival associations across molecular data types. ELOA3DP RNA expression shows survival associations in the most cancer types (11), followed by mutation status (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ELOA3DP RNA expression–survival associations across cancer types. High ELOA3DP expression shows unfavorable associations in BLCA, KICH, COAD, HNSC, LUSC and SARC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for ELOA3DP RNA expression.
This table shows molecular features associated with ELOA3DP in patient tissues and cancer cell lines. In patient samples, ELOA3DP shows the broadest associations at the RNA and protein expression levels, with BRCA recurring as the lineage with the largest associated feature set. In cancer cell lines, ELOA3DP RNA and mutation anchors are most strongly linked to RNA-expression features, especially in PANCREAS, while CRISPR and shRNA rows add functional-dependency signals in SKIN and LARGE_INTESTINE.
